Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01592370
Title Safety Study in Nivolumab Alone and in Combination With Ipilimumab or Lirilumab in Lymphoma and Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

chronic myeloid leukemia

Hodgkin's lymphoma

non-Hodgkin lymphoma

multiple myeloma

Therapies

Nivolumab

Ipilimumab

Lirilumab

Age Groups: adult
Covered Countries USA | ITA | FRA | BEL

Facility Status City State Zip Country Details
Local Institution - 0035 Clovis California 93611 United States Details
Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles California 90095 United States Details
Local Institution - 0012 Los Angeles California 90095 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Yale University School Of Medicine New Haven Connecticut 06520 United States Details
Local Institution - 0023 Orlando Florida 32804 United States Details
Local Institution - 0037 Skokie Illinois 60077 United States Details
Local Institution - 0019 Indianapolis Indiana 46202 United States Details
Local Institution - 0018 Westwood Kansas 66205 United States Details
Local Institution - 0003 Baltimore Maryland 21231 United States Details
The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Local Institution - 0009 Boston Massachusetts 02215 United States Details
Local Institution - 0015 Boston Massachusetts 02215 United States Details
Local Institution - 0011 Ann Arbor Michigan 48109 United States Details
University Of Michigan Health System Ann Arbor Michigan 48109 United States Details
Local Institution - 0002 Rochester Minnesota 55905 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Local Institution - 0014 Hackensack New Jersey 07601 United States Details
Local Institution - 0001 New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Local Institution - 0028 Columbus Ohio 43210 United States Details
Local Institution - 0006 Portland Oregon 97239 United States Details
OHSU Center for Hematologic Malignancies Portland Oregon 97239 United States Details
Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Local Institution - 0007 Philadelphia Pennsylvania 19104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Local Institution - 0004 Philadelphia Pennsylvania 19111 United States Details
Huntsman Cancer Institute At The Univ. Of Utah Salt Lake City Utah 84112 United States Details
Local Institution - 0005 Salt Lake City Utah 84112 United States Details
Local Institution - 0045 Gent 9000 Belgium Details
Local Institution Sint-Niklaas 9100 Belgium Details
Local Institution Yvoir B-5530 Belgium Details
Local Institution - 0044 Nantes Cedex 1 44000 France Details
Local Institution - 0043 Poitiers 86021 France Details
Local Institution - 0039 Athens 11528 Greece Details
Local Institution Bologna 40138 Italy Details
Local Institution Chorzow 41-500 Poland Details
Local Institution - 0040 Poznan 61-848 Poland Details
Local Institution - 0049 Warszawa 02-776 Poland Details
Local Institution - 0042 Wroclaw 50-367 Poland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field